Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

XLV vs RAGHX overlap: 49% of top holdings shared

Bottom line

How much do XLV and RAGHX overlap?

49% of their top holdings overlap by weight. 11 securities appear in both funds' top 25, making up 52.4% of XLV's assets and 57.6% of RAGHX's. They share a meaningful core but differ in the rest of the portfolio.

XLV holds far more positions (65 vs 24), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

XLVRAGHX
Weight overlap (top 25)49%
Shared holdings11
Weight in shared holdings52.4%57.6%
Total positions6524
Expense ratio0.08%1.41%
Holdings as ofJun 30, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Holdings XLV and RAGHX have in common

Holding% of XLV% of RAGHXOverlap
Eli Lilly & Co16.51%14.84%14.84%
AbbVie Inc7.74%5.52%5.52%
UnitedHealth Group Inc6.57%4.65%4.65%
Merck & Co Inc5.52%5.06%5.06%
Amgen Inc3.40%3.85%3.40%
Thermo Fisher Scientific Inc3.24%3.65%3.24%
Intuitive Surgical Inc2.45%3.89%2.45%
Vertex Pharmaceuticals Inc2.19%5.32%2.19%
Danaher Corp2.09%3.37%2.09%
McKesson Corp1.58%4.57%1.58%
Regeneron Pharmaceuticals Inc1.08%2.90%1.08%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in XLV

  1. Johnson & Johnson — 10.64%
  2. Abbott Laboratories — 2.75%
  3. Gilead Sciences Inc — 2.73%
  4. Pfizer Inc — 2.39%
  5. CVS Health Corp — 2.30%
  6. Bristol-Myers Squibb Co — 2.05%
  7. Stryker Corp — 1.89%
  8. Medtronic PLC — 1.75%
  9. Elevance Health Inc — 1.46%
  10. Cigna Group/The — 1.27%
  11. Boston Scientific Corp — 1.10%
  12. HCA Healthcare Inc — 1.05%
  13. Cardinal Health Inc — 0.97%
  14. Cencora Inc — 0.96%

Only in RAGHX

  1. West Pharmaceutical Services Inc — 5.92%
  2. Mettler-toledo International Inc — 3.99%
  3. Cooper Companies Inc (the) — 3.81%
  4. Idexx Laboratories Inc — 3.77%
  5. Lumexa Imaging Holdings Inc — 3.60%
  6. Healthequity Inc — 3.47%
  7. Dexcom Inc — 3.05%
  8. Align Technology Inc — 2.88%
  9. Steris Plc — 2.32%
  10. U.s. Physical Therapy Inc — 2.30%
  11. Globus Medical Inc — 2.21%
  12. Medline Inc — 1.88%
  13. Prestige Consumer Healthcare Inc — 1.65%

Asset mix

Asset typeXLVRAGHX
Stocks99.7%98.5%
Cash & short-term funds0.3%—

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Country mix

CountryXLVRAGHX
US97.9%96.2%
IE2.1%2.3%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do XLV and RAGHX overlap?
About 49% by weight. 11 securities appear in both funds' top 25 holdings; they make up 52.4% of XLV's assets and 57.6% of RAGHX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do XLV and RAGHX have in common?
The largest shared holdings are Eli Lilly & Co, AbbVie Inc, Merck & Co Inc, UnitedHealth Group Inc, Amgen Inc.
Should I own both XLV and RAGHX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, XLV or RAGHX?
XLV is broader, with 65 positions versus 24 for RAGHX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.